We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Ohio Taxpayers for Lower Drug Prices advocacy group accuses drugmakers of making donations aimed at influencing an election, meeting the definition of a political action committee. Read More
The FDA warned a Chinese drugmaker for inadequate testing and quality control for drug supplies and finished products, as well as numerous other GMP violations. Read More
Insys Pharmaceuticals settled with the state of Illinois for $4.45 million to settle a 2016 lawsuit over the company’s deceptive marketing of opioids, the state attorney general announced. Read More
The FDA has largely succeeded in expediting the review of drugs with larger health gains, but postmarket trials by companies have fallen behind in confirming some of those benefits, with many not using the gold standard of randomized controlled trials, according to two independent studies. Read More